NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-064-2004-0-DK-18 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT DK EP 02793811.7 Expired
NIDDK E-064-2004-0-FR-20 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT FR EP 02793811.7 Expired
NIDDK E-064-2004-0-DE-17 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT DE EP 02793811.7 Expired
NIDDK E-064-2004-0-IT-22 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT IT EP 02793811.7 Expired
NHLBI E-329-2001-0-JP-04 Stem Cells That Transform to Beating Cardiomyocytes JP National Stage 2003-538339 Abandoned
NIDDK E-064-2004-0-AU-12 The Use Of Leptin For Treating Human Lipotrophy AU National Stage 2002359288 Expired
NHLBI E-329-2001-0-AU-03 Stem Cells That Transform to Beating Cardiomyocytes AU National Stage 2002337949 Abandoned
NIDDK E-064-2004-0-MX-05 The Use Of Leptin For Treating Human Lipotrophy MX National Stage PA/a/2004/003773 Expired
NHLBI E-329-2001-0-EP-06 Stem Cells That Transform to Beating Cardiomyocytes EP National Stage 02773854.1 Abandoned
NIDDK E-064-2004-0-PCT-02 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT PCT PCT PCT/US2002/033875 Expired
NIDDK E-064-2004-0-JP-04 The Use Of Leptin For Treating Human Lipoatrophy JP National Stage 2003-537565 Abandoned
NHLBI E-329-2001-0-PCT-02 Stem Cells That Transform to Beating Cardiomyocytes PCT PCT PCT/US02/33860 Expired
NCI E-256-2002-0-US-01 Method of Reducing the Activity of and Reducing the Concentration of a Mutant Kit Protein. US 60/420,143 Abandoned
NIDDK E-064-2004-0-US-03 The Use Of Leptin For Treating Human Lipotrophy US National Stage 10/279,129 Abandoned
NHLBI E-329-2001-0-CA-05 Stem Cells That Transform to Beating Cardiomyocytes CA National Stage 2464088 Abandoned
NIA E-246-2002-0-US-01 MKp-1: A Screen for Anti-Inflammatory Drugs US 60/420,272 Abandoned
NCI E-307-2002-0-US-01 Sheathless CE-ESI-MS Interface US 60/420,003 Abandoned
NCI E-030-2000-0-PCT-02 ABCA8 NUCLEIC ACIDS AND PROTEINS, AND USES THEREOF PCT PCT PCT/US02/33496 Expired
NCI E-292-2001-1-PCT-01 Use of Mx GTPases in The Prognosis And Treatment of Cancer PCT PCT COMB PCT/US02/33232 Expired
NIAAA E-101-2004-0-PCT-02 Use Of Inhibitors Of The Y2 Receptor Of Neuropeptide Y In The Treatment Of Alcoholism PCT PCT PCT/US02/01902 Expired
NIAAA E-101-2004-0-US-03 Use Of Inhibitors Of The Y2 Receptor Of Neuropeptide Y In The Treatment Of Alcoholism US National Stage 10/492,785 Abandoned
NHGRI E-020-2003-0-US-01 Molecular Abnormalities On Chromosome 1q In Hutchinson-Gilford Progeria Syndrome - HGPS US 60/419,541 Abandoned
NIMH E-348-2003-0-US-01 Methods And Formulations Comprising Agonists And Antagonists Of Nuclear Hormone Receptors US 60/419,454 Abandoned
NIAMS E-353-2001-2-PCT-01 Methods of Using Deacetylase Inhibitors as Tools To Promote Cell Differentiation And Regeneration PCT PCT COMB PCT/US2002/033570 Expired
NHLBI E-361-2001-0-PCT-02 A Method and Apparatus to Improve an MRI Image PCT PCT PCT/US2002/033571 Expired
CC E-207-2001-1-US-02 BIOPSY APPARATUS WITH RADIO FREQUENCY CAUTERIZATION AND METHODS FOR ITS USE US ORD 10/274,074 Abandoned
NIMH E-242-2003-0-US-01 Direct Use Of Tissue To Isolate Anti-HDS Modified Phage/ US 60/418,722 Abandoned
NCI E-130-2001-0-IN-06 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes IN National Stage 1073/CHEN/2004 Abandoned
NCI E-130-2001-0-AU-02 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes AU National Stage 2002337885 Abandoned
NCI E-130-2001-0-PCT-01 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes PCT PCT PCT/US02/33165 Abandoned
NCI E-046-1991-5-US-03 METHOD OF PREVENTING TUMOR METASTASIS (AS FILED) US CON 10/270,564 Abandoned
NCI E-123-2003-0-US-01 Methods Of Treating Melanoma Using Cosalane US 60/419,058 Abandoned
NCI E-096-2003-0-US-01 Use Of DDR1 And Agents That Affect The DDR1/Collagen Pathway US 60/419,179 Abandoned
NCI E-130-2001-0-CA-04 Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By ENV-CD4-CO-Receptor Complexes CA National Stage 2463931 Abandoned
NCI E-297-2002-0-CA-03 Methods of Preparing Lymphocytes That Express Interleukin-2 and Their Use in the Treatment of Cancer CA National Stage 2501087 Abandoned
NCI E-297-2002-0-AU-04 Methods of Preparing Lymphocytes that Express Interleukin-2 and their Use in the Treatment of Cancer AU National Stage 2002353822 Abandoned
NCI E-297-2002-0-PCT-01 Methods of Preparing Lymphocytes that Express Interleukins-2 and Their Use in the Treatment of Cancer PCT PCT PCT/US2002/033243 Expired
NIA E-146-1993-0-US-10 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 10/272,496 Abandoned
NCI E-297-2002-0-EP-05 Methods of Preparing Lymphocytes that Express Interleukins-2 and Their Use in the Treatment of Cancer EP National Stage 02789213.2 Abandoned
NHLBI E-259-2002-0-US-01 Identification and Purification of Pulmonary Hypertensive Substances From Group B Streptococcus US 60/419,035 Abandoned
NIMH E-098-2001-1-US-01 Methods of Manipulating Nucleic Acids US CIP 10/269,515 Abandoned
NIDCR E-308-2003-1-US-01 Ligands of Eukarytic Translation Initiation Factor 5A (eIF-5A) and Their Use US 60/417,738 Abandoned
NCI E-121-2002-0-US-01 Identification of Anti-HIV Compounds Inhibiting Virus Assembly and Binding of Nucleocapsid Protein to Nucleic Acid US 60/416,854 Abandoned
NCI E-171-2000-0-JP-03 Highly Cross-Linked, Extremely Hydrophobic Nitric Oxide-Releaseing Polymers And Methods For Their Manufacture And Use JP ORD 2002-292578 Expired
NIDA E-057-2000-0-US-03 TREATMENT OF NEUROPSYCHIATRIC DISEASE WITH PROTEASE AND NEURAMINIDASE INHIBITORS US National Stage 10/182,162 Abandoned
NIMH E-247-2002-0-US-01 Anthrax Lethal Factor Represses the Glucocorticoid Receptor and Other Nuclear Receptors: Possible Role in Toxicity of Anthrax, Related Bacterial Products and Related Vaccines US 60/416,222 Abandoned
NCI E-293-2002-0-US-01 Vasoregulating Compounds and Methods of Their Use US 60/416,291 Abandoned
NCI E-158-2001-0-PCT-01 Tandem Repeat Markers PCT PCT PCT/US02/031634 Expired
NIA E-138-2000-0-US-03 Tumor Markers in Ovarian Cancer US National Stage 10/257,021 7279294 Abandoned PDF
NIMH E-038-2007-3-PCT-02 Nucleic Acid Molecules, Polypeptides And Uses Therefor, Including Diagnosis And Treatment Of Alzheimer's Disease PCT PCT PCT/US02/31642 Expired